pubmed-article:18423312 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18423312 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
pubmed-article:18423312 | lifeskim:mentions | umls-concept:C2350570 | lld:lifeskim |
pubmed-article:18423312 | lifeskim:mentions | umls-concept:C0025962 | lld:lifeskim |
pubmed-article:18423312 | lifeskim:mentions | umls-concept:C1522720 | lld:lifeskim |
pubmed-article:18423312 | lifeskim:mentions | umls-concept:C0205282 | lld:lifeskim |
pubmed-article:18423312 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:18423312 | lifeskim:mentions | umls-concept:C0178587 | lld:lifeskim |
pubmed-article:18423312 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
pubmed-article:18423312 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
pubmed-article:18423312 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
pubmed-article:18423312 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:18423312 | pubmed:dateCreated | 2008-4-21 | lld:pubmed |
pubmed-article:18423312 | pubmed:abstractText | Malignant mesothelioma (MM) of the pleura is an aggressive and often fatal neoplasm. Because MM frequently demonstrates marked angiogenesis, it may be responsive to antiangiogenic therapy, but effective methods for selecting and monitoring of patients are further needed. We employed dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and quantitative immunohistochemistry (IHC) to characterize the microvascularity of MM using both a physiologic and ultrastructural method. | lld:pubmed |
pubmed-article:18423312 | pubmed:language | eng | lld:pubmed |
pubmed-article:18423312 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18423312 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18423312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18423312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18423312 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18423312 | pubmed:month | May | lld:pubmed |
pubmed-article:18423312 | pubmed:issn | 1076-6332 | lld:pubmed |
pubmed-article:18423312 | pubmed:author | pubmed-author:WeberM AMA | lld:pubmed |
pubmed-article:18423312 | pubmed:author | pubmed-author:ChoykePeter... | lld:pubmed |
pubmed-article:18423312 | pubmed:author | pubmed-author:EssigMarcoM | lld:pubmed |
pubmed-article:18423312 | pubmed:author | pubmed-author:KnoppMichael... | lld:pubmed |
pubmed-article:18423312 | pubmed:author | pubmed-author:KauczorHans-U... | lld:pubmed |
pubmed-article:18423312 | pubmed:author | pubmed-author:KayserKlausK | lld:pubmed |
pubmed-article:18423312 | pubmed:author | pubmed-author:DelormeStefan... | lld:pubmed |
pubmed-article:18423312 | pubmed:author | pubmed-author:GieselFrederi... | lld:pubmed |
pubmed-article:18423312 | pubmed:author | pubmed-author:HintzeChristi... | lld:pubmed |
pubmed-article:18423312 | pubmed:author | pubmed-author:BischoffHelge... | lld:pubmed |
pubmed-article:18423312 | pubmed:author | pubmed-author:ZechmannChris... | lld:pubmed |
pubmed-article:18423312 | pubmed:author | pubmed-author:MehndirattaAm... | lld:pubmed |
pubmed-article:18423312 | pubmed:author | pubmed-author:von... | lld:pubmed |
pubmed-article:18423312 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18423312 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:18423312 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18423312 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18423312 | pubmed:pagination | 563-70 | lld:pubmed |
pubmed-article:18423312 | pubmed:meshHeading | pubmed-meshheading:18423312... | lld:pubmed |
pubmed-article:18423312 | pubmed:meshHeading | pubmed-meshheading:18423312... | lld:pubmed |
pubmed-article:18423312 | pubmed:meshHeading | pubmed-meshheading:18423312... | lld:pubmed |
pubmed-article:18423312 | pubmed:meshHeading | pubmed-meshheading:18423312... | lld:pubmed |
pubmed-article:18423312 | pubmed:meshHeading | pubmed-meshheading:18423312... | lld:pubmed |
pubmed-article:18423312 | pubmed:meshHeading | pubmed-meshheading:18423312... | lld:pubmed |
pubmed-article:18423312 | pubmed:meshHeading | pubmed-meshheading:18423312... | lld:pubmed |
pubmed-article:18423312 | pubmed:meshHeading | pubmed-meshheading:18423312... | lld:pubmed |
pubmed-article:18423312 | pubmed:meshHeading | pubmed-meshheading:18423312... | lld:pubmed |
pubmed-article:18423312 | pubmed:meshHeading | pubmed-meshheading:18423312... | lld:pubmed |
pubmed-article:18423312 | pubmed:meshHeading | pubmed-meshheading:18423312... | lld:pubmed |
pubmed-article:18423312 | pubmed:meshHeading | pubmed-meshheading:18423312... | lld:pubmed |
pubmed-article:18423312 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18423312 | pubmed:articleTitle | Pharmacokinetic analysis of malignant pleural mesothelioma-initial results of tumor microcirculation and its correlation to microvessel density (CD-34). | lld:pubmed |
pubmed-article:18423312 | pubmed:affiliation | Radiologie, German Cancer Research Center (DKFZ), INF 280, 69120 Heidelberg, Germany. f.giesel@egiesel.com | lld:pubmed |
pubmed-article:18423312 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18423312 | lld:pubmed |